Tandem Diabetes Care Names Jeannette Bankes as President and Chief Executive Officer
Tandem Diabetes Care named Jeannette Bankes as president and CEO and board member, effective November 16, 2026, succeeding John Sheridan as part of a planned leadership transition. Sheridan, CEO since 2019 and with the company since 2013, retires at the end of 2026 and will remain a consultant to support the handover. Bankes brings 30+ years of healthcare operating experience, most recently as CEO of GE HealthCare's $3.1 billion Patient Care Solutions segment, and previously held senior roles at Alcon, Merck, and Boston Scientific.
Key figures
- Effective date
- November 16, 2026
- Inducement award usd
- $10,000,000
- Prior segment revenue
- $3.1 billion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.